Auna S.A. (NYSE:AUNA) Given Average Rating of "Hold" by Analysts

Key Points

• Analysts give Auna a consensus “Hold” rating among five firms, with one sell, two hold, one buy and one strong-buy rating. The average 12-month price target is $6.97, above the reported opening price of $5.12.
• Auna’s latest quarterly earnings missed expectations, with adjusted earnings of $0.15 per share versus the $0.26 consensus estimate, although revenue of $362.85 million exceeded forecasts.
• The stock was down 2.0% and trades near its 52-week range, while several institutional investors—including Renaissance Technologies and Bank of America—recently increased their positions.

Auna S.A. (NYSE:AUNA - Get Free Report) has been assigned a consensus rating of "Hold" from the five ratings firms that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, one has assigned a buy rating and one has given a strong buy rating to the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $6.9667.

Several research firms have commented on AUNA. Weiss Ratings reiterated a "sell (d)" rating on shares of Auna in a research report on Wednesday, June 24th. JPMorgan Chase & Co. reduced their target price on shares of Auna from $6.00 to $5.00 and set a "neutral" rating on the stock in a report on Tuesday, May 26th. Finally, Wall Street Zen cut shares of Auna from a "strong-buy" rating to a "buy" rating in a research report on Sunday, July 5th.

Auna Stock Down 2.0%

Shares of AUNA opened at $5.12 on Friday. The stock has a market capitalization of $379.30 million, a price-to-earnings ratio of 73.22 and a beta of 0.61. Auna has a 1 year low of $4.09 and a 1 year high of $6.85. The business's 50 day simple moving average is $5.19 and its 200-day simple moving average is $5.14. The company has a debt-to-equity ratio of 1.61, a current ratio of 1.08 and a quick ratio of 1.00.

Auna (NYSE:AUNA - Get Free Report) last posted its earnings results on Tuesday, August 18th. The company reported $0.15 earnings per share for the quarter, missing analysts' consensus estimates of $0.26 by ($0.11). Auna had a net margin of 0.44% and a return on equity of 12.88%. The business had revenue of $362.85 million during the quarter, compared to analysts' expectations of $357.39 million. As a group, equities analysts expect that Auna will post 0.79 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Auna

Several large investors have recently added to or reduced their stakes in the stock. AXQ Capital LP raised its position in Auna by 72.3% during the second quarter. AXQ Capital LP now owns 24,637 shares of the company's stock valued at $126,000 after purchasing an additional 10,335 shares during the period. Bank of America Corp DE boosted its stake in shares of Auna by 255.9% during the 1st quarter. Bank of America Corp DE now owns 16,886 shares of the company's stock worth $93,000 after purchasing an additional 12,142 shares during the period. Lazard Asset Management LLC bought a new position in Auna during the 1st quarter valued at about $557,000. Renaissance Technologies LLC grew its stake in shares of Auna by 487.7% during the first quarter. Renaissance Technologies LLC now owns 668,457 shares of the company's stock valued at $3,683,000 after buying an additional 554,707 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership bought a new position in Auna in the 1st quarter valued at $316,000.

About Auna

Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna's organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.

The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source